Hyaluronan, a non-sulfated glycosaminoglycan, has two major receptors, CD44 and RHAMM, which mediate its roles in inflammation and cancer (Toole, 2009; Misra et al., 2015; Nikitovic et al., 2015). The gene discussed is CD44; the disease is cancer.